NXTC
Price
$4.76
Change
-$0.33 (-6.48%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
13.03M
80 days until earnings call
OKYO
Price
$3.12
Change
-$0.15 (-4.59%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
122.99M
23 days until earnings call
Interact to see
Advertisement

NXTC vs OKYO

Header iconNXTC vs OKYO Comparison
Open Charts NXTC vs OKYOBanner chart's image
NextCure
Price$4.76
Change-$0.33 (-6.48%)
VolumeN/A
Capitalization13.03M
OKYO Pharma
Price$3.12
Change-$0.15 (-4.59%)
Volume$1.78K
Capitalization122.99M
NXTC vs OKYO Comparison Chart in %
Loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. OKYO commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and OKYO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (NXTC: $5.09 vs. OKYO: $3.27)
Brand notoriety: NXTC and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 0% vs. OKYO: 55%
Market capitalization -- NXTC: $13.03M vs. OKYO: $122.99M
NXTC [@Biotechnology] is valued at $13.03M. OKYO’s [@Biotechnology] market capitalization is $122.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, both NXTC and OKYO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 3 TA indicator(s) are bullish while OKYO’s TA Score has 3 bullish TA indicator(s).

  • NXTC’s TA Score: 3 bullish, 5 bearish.
  • OKYO’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, OKYO is a better buy in the short-term than NXTC.

Price Growth

NXTC (@Biotechnology) experienced а +4.19% price change this week, while OKYO (@Biotechnology) price change was +21.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

NXTC is expected to report earnings on Oct 30, 2025.

OKYO is expected to report earnings on Sep 03, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OKYO($123M) has a higher market cap than NXTC($13M). OKYO YTD gains are higher at: 184.373 vs. NXTC (-44.931).
NXTCOKYONXTC / OKYO
Capitalization13M123M11%
EBITDAN/AN/A-
Gain YTD-44.931184.373-24%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash15.4MN/A-
Total Debt4.91MN/A-
FUNDAMENTALS RATINGS
NXTC: Fundamental Ratings
NXTC
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NXTCOKYO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
57%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HBNC15.220.19
+1.26%
Horizon Bancorp
CBOE252.583.08
+1.23%
Cboe Global Markets
TAIT2.11-0.02
-0.94%
Taitron Components
MTSR30.40-0.49
-1.59%
Metsera Inc
KYTX3.24-0.07
-2.11%
Kyverna Therapeutics

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with ACET. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
N/A
ACET - NXTC
34%
Loosely correlated
-9.62%
SRPT - NXTC
31%
Poorly correlated
+1.50%
OKYO - NXTC
29%
Poorly correlated
+3.48%
MBIO - NXTC
27%
Poorly correlated
+9.21%
CLRB - NXTC
26%
Poorly correlated
+0.42%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
+3.48%
XRTX - OKYO
28%
Poorly correlated
+2.58%
DYN - OKYO
28%
Poorly correlated
N/A
ACUT - OKYO
28%
Poorly correlated
+1.57%
NXTC - OKYO
28%
Poorly correlated
N/A
MRNA - OKYO
26%
Poorly correlated
-1.84%
More